Crossmark

Motivational interviewing to increase drug checking and reduce overdose rates among people who use drugs: protocol for a hybrid type 1 effectiveness–implementation trial of an adjunctive intervention

Crossref DOI link: https://doi.org/10.1186/s12889-025-24460-y

Published Online: 2025-09-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bailey, Katie

Strathdee, Steffanie A.

Bazzi, Angela R.

Stamos-Buesig, Tara

Godvin, Morgan

Harvey-Vera, Alicia

Abramovitz, Daniela

Vera, Carlos F.

Patterson, Thomas L.

Davidson, Peter J.

Bórquez, Annick
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct06855836 at ClinicalTrials.gov

Documents that mention this clinical trial

Motivational interviewing to increase drug checking and reduce overdose rates among people who use drugs: protocol for a hybrid type 1 effectiveness–implementation trial of an adjunctive intervention
https://doi.org/10.1186/s12889-025-24460-y
Funding

Funding for this research was provided by:

National Institute on Drug Abuse (T32DA023356)

National Institute on Drug Abuse (R33DA061260)

National Institute on Drug Abuse (R33DA061260)

National Institute on Drug Abuse (R33DA061260)

National Institute on Drug Abuse (R33DA061260)

National Institute on Drug Abuse (R33DA061260)
License Information

Text and Data Mining valid from 2025-09-30

Version of Record valid from 2025-09-30
More Information

Article History

Received: 8 July 2025

Accepted: 15 August 2025

First Online: 30 September 2025

Declarations

:

: Study procedures were approved by The University of California San Diego Institutional Review Board (IRB) on May 29, 2024 (protocol # 810285).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below